ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
Clinical trial NCT01903330 · UNKNOWN
Trial details
- NCT number
- NCT01903330
- Sponsor
- Epitopoietic Research Corporation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2026-03-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.